A new trading day began on Friday, with Opus Genetics Inc (NASDAQ: IRD) stock price up 16.75% from the previous day of trading, before settling in for the closing price of $1.97. IRD’s price has ranged from $0.65 to $2.16 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 24.32% over the last five years. Meanwhile, its annual earnings per share averaged 73.62%. With a float of $26.07 million, this company’s outstanding shares have now reached $59.91 million.
The firm has a total of 18 workers. Let’s measure their productivity.
Opus Genetics Inc (IRD) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Opus Genetics Inc is 56.48%, while institutional ownership is 23.09%. The most recent insider transaction that took place on Dec 26 ’24, was worth 97,600. In this transaction Chief Executive Officer of this company bought 100,000 shares at a rate of $0.98, taking the stock ownership to the 599,150 shares. Before that another transaction happened on Nov 21 ’24, when Company’s President bought 10,000 for $0.98, making the entire transaction worth $9,834. This insider now owns 342,800 shares in total.
Opus Genetics Inc (IRD) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.29 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.88% during the next five years compared to 24.32% growth over the previous five years of trading.
Opus Genetics Inc (NASDAQ: IRD) Trading Performance Indicators
Here are Opus Genetics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.76, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Opus Genetics Inc (IRD)
Analysing the last 5-days average volume posted by the [Opus Genetics Inc, IRD], we can find that recorded value of 0.65 million was better than the volume posted last year of 0.51 million. As of the previous 9 days, the stock’s Stochastic %D was 73.20%.
During the past 100 days, Opus Genetics Inc’s (IRD) raw stochastic average was set at 99.80%, which indicates a significant increase from 99.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.13 in the past 14 days, which was higher than the 0.09 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.68, while its 200-day Moving Average is $1.19. Now, the first resistance to watch is $2.42. This is followed by the second major resistance level at $2.53. The third major resistance level sits at $2.76. If the price goes on to break the first support level at $2.07, it is likely to go to the next support level at $1.84. Now, if the price goes above the second support level, the third support stands at $1.73.
Opus Genetics Inc (NASDAQ: IRD) Key Stats
With a market capitalization of 137.79 million, the company has a total of 59,908K Shares Outstanding. Currently, annual sales are 10,990 K while annual income is -57,530 K. The company’s previous quarter sales were 2,880 K while its latest quarter income was -7,420 K.
